BioVaxys Technology's market cap is currently $8.99M. The company's EPS TTM is $-0.021; its P/E ratio is ―; BioVaxys Technology is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Operating Income	C$ -2.40M	C$ -4.08M	C$ -6.42M	C$ -1.09M	C$ -229.69K
EBITDA	C$ -7.69M	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Net Income	C$ -7.69M	C$ -19.36M	C$ -6.47M	C$ -1.18M	C$ -230.33K
Balance Sheet
Cash & Short-Term Investments	C$ 977.00	C$ 141.90K	C$ 593.12K	C$ 2.42M	C$ 228.98K
Total Assets	C$ 113.48K	C$ 865.56K	C$ 8.50M	C$ 10.46M	C$ 306.26K
Total Debt	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Net Debt	C$ -977.00	C$ -141.90K	C$ -593.12K	C$ -2.42M	C$ -228.98K
Total Liabilities	C$ 3.49M	C$ 1.64M	C$ 326.86K	C$ 900.09K	C$ 116.15K
Stockholders' Equity	C$ -3.37M	C$ -773.53K	C$ 8.18M	C$ 9.56M	C$ 190.11K
Cash Flow
Free Cash Flow	C$ -1.05M	C$ -1.57M	C$ -5.29M	C$ -1.23M	C$ -230.76K
Operating Cash Flow	C$ -1.05M	C$ -1.57M	C$ -5.29M	C$ -1.23M	C$ -230.76K
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	C$ 61.36K	C$ -13.23K
Financing Cash Flow	C$ 917.10K	C$ 1.11M	C$ 3.44M	C$ 3.35M	C$ 444.09K

Currency in CAD

BioVaxys Technology Earnings and Revenue History

Income Statement >

BioVaxys Technology Debt to Assets

Balance Sheet >

BioVaxys Technology Cash Flow

Cash Flow >

BioVaxys Technology Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing